12-Nov-2024 3:05 PM CST - Business Wire Innoviva to Participate in the UBS Global Healthcare Conference Innoviva, Inc. (NASDAQ: INVA) (Innoviva or the Company), a diversified holding company with a core royalties portfolio, a leading critical care and infectious disease platform known as Innoviva Specialty Therapeutics (IST), and a portfolio of strategic investments in healthcare assets, today announced that management will participate in a fireside chat at the UBS Global Healthcare Conference in Ranch Palos Verdes, CA on Wednesday, November 13, 2024 at
6-Nov-2024 3:05 PM CST - Business Wire Innoviva Reports Third Quarter 2024 Financial Results; Highlights Recent Company Progress Innoviva, Inc. (NASDAQ: INVA) (Innoviva or the Company), a diversified holding company with a core royalties portfolio, a leading critical care and infectious disease platform known as Innoviva Specialty Therapeutics (IST), and a portfolio of strategic investments in healthcare assets, today reported financial results for the third quarter ended September 30, 2024, and highlighted select corporate achievements. For the third quarter of 2024, we contin
12-Nov-2024 3:05 PM CST - Business Wire Innoviva to Participate in the UBS Global Healthcare Conference Innoviva, Inc. (NASDAQ: INVA) (Innoviva or the Company), a diversified holding company with a core royalties portfolio, a leading critical care and infectious disease platform known as Innoviva Specialty Therapeutics (IST), and a portfolio of strategic investments in healthcare assets, today announced that management will participate in a fireside chat at the UBS Global Healthcare Conference in Ranch Palos Verdes, CA on Wednesday, November 13, 2024 at
6-Nov-2024 3:05 PM CST - Business Wire Innoviva Reports Third Quarter 2024 Financial Results; Highlights Recent Company Progress Innoviva, Inc. (NASDAQ: INVA) (Innoviva or the Company), a diversified holding company with a core royalties portfolio, a leading critical care and infectious disease platform known as Innoviva Specialty Therapeutics (IST), and a portfolio of strategic investments in healthcare assets, today reported financial results for the third quarter ended September 30, 2024, and highlighted select corporate achievements. For the third quarter of 2024, we contin